Laura L. Parks appointed President and Business Unit Director at DSM Pharmaceutical Products

Laura L. Parks, Ph.D., currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM has been appointed President and Business Unit Director of DSM Pharmaceuticals as of June 1, 2012.

Laura will continue to report to Alexander R. Wessels, President and Chief Executive Officer of DSM Pharmaceutical Products, as a member of the Management Team.

 

Dr. Parks joined DSM in 2008. Prior to DSM, she was with World Financial Group, and Solae (a Division of DuPont), a public company of over 10,000 employees, as Vice President of Sales.

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.